Search

everythinglearnresearchcommunity

for

Search:↓

Ixekizumab successfully treated a rare hair loss condition, leading to complete hair regrowth.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

Personalized treatments for hair loss are becoming more effective by using genetic information.

The C3H/HeJ mouse model is useful for studying and testing treatments for alopecia areata.

The document concludes that there have been significant advances in the treatment and diagnosis of various skin conditions.

Topical corticosteroids are the best initial treatment for children's alopecia areata.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

Long-haul COVID can cause lasting symptoms affecting many body systems and may be linked to ongoing inflammation and immune system issues.

Vitamin D is important for bones, hair, blood pressure, and breast development.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

Non-coding RNAs could help detect and treat radiation damage.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

The document concludes that more research is needed to find effective treatments for Lichen planopilaris and Frontal fibrosing alopecia.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.

Synthetic antioxidants are effective, cheap, and stable, with some like zinc and cholecalciferol reducing child and cancer deaths, but the safety of additives like BHA, BHT, TBHQ, and PEG needs more research.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

EDA signaling is linked to skin disorders, various cancers, and liver disease.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

Some drugs used to treat immune conditions may cause different types of hair loss.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

High levels of ERK activity are key for tissue regeneration in spiny mice, and activating ERK can potentially redirect scar-forming healing towards regenerative healing in mammals.

Topical corticosteroids are the main treatment for Erosive Pustular Dermatosis, but recurrence is common after stopping treatment.

Stem-cell therapy shows promise for skin conditions but needs more research.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

The guide explains how to study human skin fat cells and their tissue, aiming to improve research and medical treatments.

Stem cell plasticity is crucial for wound healing but can also contribute to cancer development.